MedTrace Logo

Evaluation of the Impact of the SMART ANGEL ™ Device on Follow-up at Home Following Major or Intermediate Outpatient Surgery

NCT04068584 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1260

Last updated 2026-05-14

No results posted yet for this study

Summary

The investigators hypothesize that by monitoring and analyzing physiological parameters (heart rate, blood pressure, saturation) and well-being (pain, nausea, vomiting, comfort) the SMART ANGEL ™ device improves the quality of care after major or intermediate outpatient surgery. This active surveillance will result in a decrease in the rate of unplanned recourse (hospitalization, consultation, telephone call).

Conditions

  • Ambulatory Surgery

Interventions

OTHER

Smart Angel

Patient issued with a tablet with the Smart Angel application to monitor clinical signs and symptoms

Sponsors & Collaborators

  • Evolucare Technologies

    collaborator INDUSTRY

  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Principal Investigators

  • Christhophe Boisson · CHU Nimes

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-03
Primary Completion
2024-10-21
Completion
2024-11-18

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04068584 on ClinicalTrials.gov